RHHBF
Price
$372.05
Change
-$11.11 (-2.90%)
Updated
Oct 17 closing price
Capitalization
285.23B
RHHBY
Price
$44.91
Change
+$0.24 (+0.54%)
Updated
Oct 17 closing price
Capitalization
285.23B
5 days until earnings call
Interact to see
Advertisement

RHHBF vs RHHBY

Header iconRHHBF vs RHHBY Comparison
Open Charts RHHBF vs RHHBYBanner chart's image
Roche Holding
Price$372.05
Change-$11.11 (-2.90%)
Volume$64
Capitalization285.23B
Roche Holding
Price$44.91
Change+$0.24 (+0.54%)
Volume$1.51M
Capitalization285.23B
RHHBF vs RHHBY Comparison Chart in %
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RHHBF vs. RHHBY commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RHHBF is a Hold and RHHBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (RHHBF: $372.05 vs. RHHBY: $44.91)
Brand notoriety: RHHBF and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RHHBF: 30% vs. RHHBY: 109%
Market capitalization -- RHHBF: $285.23B vs. RHHBY: $285.23B
RHHBF [@Pharmaceuticals: Major] is valued at $285.23B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $285.23B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $719.7B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $94.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RHHBF’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 2 green FA rating(s).

  • RHHBF’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 2 green, 3 red.
According to our system of comparison, both RHHBF and RHHBY are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RHHBF’s TA Score shows that 4 TA indicator(s) are bullish while RHHBY’s TA Score has 3 bullish TA indicator(s).

  • RHHBF’s TA Score: 4 bullish, 5 bearish.
  • RHHBY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RHHBF is a better buy in the short-term than RHHBY.

Price Growth

RHHBF (@Pharmaceuticals: Major) experienced а -4.11% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was -1.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.16%. For the same industry, the average monthly price growth was +1.84%, and the average quarterly price growth was +19.16%.

Reported Earning Dates

RHHBY is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBF($285B) and RHHBY($285B) have the same market capitalization . RHHBF (25.25) and RHHBY (24.38) have similar P/E ratio . RHHBY YTD gains are higher at: 33.037 vs. RHHBF (23.530). RHHBF (18B) and RHHBY (18B) have comparable annual earnings (EBITDA) . RHHBF (12B) and RHHBY (12B) have equal amount of cash in the bank . RHHBF (33B) and RHHBY (33B) have identical debt. RHHBF (63.5B) and RHHBY (63.5B) have equivalent revenues.
RHHBFRHHBYRHHBF / RHHBY
Capitalization285B285B100%
EBITDA18B18B100%
Gain YTD23.53033.03771%
P/E Ratio25.2524.38104%
Revenue63.5B63.5B100%
Total Cash12B12B100%
Total Debt33B33B100%
FUNDAMENTALS RATINGS
RHHBF vs RHHBY: Fundamental Ratings
RHHBF
RHHBY
OUTLOOK RATING
1..100
8518
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
8977
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4747
P/E GROWTH RATING
1..100
3328
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (13) in the null industry is in the same range as RHHBF (15). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's Profit vs Risk Rating (77) in the null industry is in the same range as RHHBF (89). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's SMR Rating (99) in the null industry is in the same range as RHHBF (99). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's Price Growth Rating (47) in the null industry is in the same range as RHHBF (47). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

RHHBY's P/E Growth Rating (28) in the null industry is in the same range as RHHBF (33). This means that RHHBY’s stock grew similarly to RHHBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RHHBFRHHBY
RSI
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
49%
Momentum
ODDS (%)
Bearish Trend 1 day ago
53%
Bearish Trend 1 day ago
47%
MACD
ODDS (%)
Bearish Trend 1 day ago
50%
Bearish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
55%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
51%
Advances
ODDS (%)
Bullish Trend 9 days ago
62%
Bullish Trend 1 day ago
52%
Declines
ODDS (%)
Bearish Trend 11 days ago
56%
Bearish Trend 4 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
42%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 3 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNKS0.730.17
+30.36%
Linkers Industries Ltd
BSBR5.260.05
+0.96%
Banco Santander (Brasil) SA
SVRA3.610.03
+0.84%
Savara
SERA3.20-0.14
-4.19%
Sera Prognostics
GRAL78.00-8.41
-9.73%
GRAIL Inc.

RHHBF and

Correlation & Price change

A.I.dvisor tells us that RHHBF and RHHBY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RHHBF and RHHBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBF
1D Price
Change %
RHHBF100%
-2.90%
RHHBY - RHHBF
32%
Poorly correlated
+0.54%
RHHVF - RHHBF
25%
Poorly correlated
-0.31%
NVS - RHHBF
20%
Poorly correlated
+0.50%
JNJ - RHHBF
16%
Poorly correlated
+0.57%
ABBV - RHHBF
16%
Poorly correlated
+1.19%
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+0.54%
RHHVF - RHHBY
65%
Loosely correlated
-0.31%
NVS - RHHBY
37%
Loosely correlated
+0.50%
JNJ - RHHBY
37%
Loosely correlated
+0.57%
RHHBF - RHHBY
32%
Poorly correlated
-2.90%
BMY - RHHBY
28%
Poorly correlated
+0.55%
More